131 assets in Metabolic Dysfunction-Associated Steatotic Liver Disease

Therapeutic assets addressing Metabolic Dysfunction-Associated Steatotic Liver Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Vilagletistat Metabolic Dysfunction-Associated Steatotic Liver Disease	Dr. Falk Pharma GmbH	P2	B (57)
Linagliptin Metabolic Dysfunction-Associated Steatotic Liver Disease	Zhujiang Hospital	P4	B (56)
Glucagon Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1/2	CCC (55)
Human Faecal Matter Metabolic Dysfunction-Associated Steatotic Liver Disease	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P2	CCC (55)
Synthetic Levothyroxine Metabolic Dysfunction-Associated Steatotic Liver Disease	Post Graduate Institute of Medical Education and Research, Chandigarh	P2	CCC (55)
Tesamorelin Metabolic Dysfunction-Associated Steatotic Liver Disease	Hudson Biotech	P2	CCC (55)
Dimethyl 4,4'-Biphenyldicarboxylate Metabolic Dysfunction-Associated Steatotic Liver Disease	Yoon Jun Kim	P3	CCC (54)
gsk4532990 Metabolic Dysfunction-Associated Steatotic Liver Disease	GlaxoSmithKline	P2	CCC (54)
Tipelukast Metabolic Dysfunction-Associated Steatotic Liver Disease	MediciNova	P2	CCC (54)
Bis-Octanoyl -1,3-Butanediol Metabolic Dysfunction-Associated Steatotic Liver Disease	Washington University School of Medicine	P2	CCC (53)
coq10 Metabolic Dysfunction-Associated Steatotic Liver Disease	Ain Shams University	P2	CCC (53)
dr10624 Metabolic Dysfunction-Associated Steatotic Liver Disease	Zhejiang Doer Biologics Co., Ltd.	P2	CCC (53)
Dynamos Metabolic Dysfunction-Associated Steatotic Liver Disease	Yale University	P2	CCC (53)
hp515 Metabolic Dysfunction-Associated Steatotic Liver Disease	Hinova Pharmaceuticals Inc.	P2	CCC (53)
K-13675, (R)- Metabolic Dysfunction-Associated Steatotic Liver Disease	Yokohama City University	P2	CCC (53)
Multiple Vitamins Injection Metabolic Dysfunction-Associated Steatotic Liver Disease	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	P2	CCC (53)
Osyritrin Metabolic Dysfunction-Associated Steatotic Liver Disease	Ain Shams University	P2	CCC (53)
S,S-Adenosylmethionine Metabolic Dysfunction-Associated Steatotic Liver Disease	Cedars-Sinai Medical Center	P2	CCC (53)
Tlc-2716 Metabolic Dysfunction-Associated Steatotic Liver Disease	OrsoBio, Inc	P2	CCC (53)
Aspirin Metabolic Dysfunction-Associated Steatotic Liver Disease	Galala University	P1/2	CCC (52)
Carbocysteine Metabolic Dysfunction-Associated Steatotic Liver Disease	Tanta University	P2	CCC (51)
hu6 Metabolic Dysfunction-Associated Steatotic Liver Disease	Rivus Pharmaceuticals, Inc.	P2	CCC (51)
Maltodextrin Metabolic Dysfunction-Associated Steatotic Liver Disease	Peking Union Medical College Hospital	P2	CCC (51)
q10 Metabolic Dysfunction-Associated Steatotic Liver Disease	Attikon Hospital	P2	CCC (51)
Dasatinib Metabolic Dysfunction-Associated Steatotic Liver Disease	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P1/2	CCC (48)
Flavone, 3,3',4',5,7-Pentahydroxy- Metabolic Dysfunction-Associated Steatotic Liver Disease	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P1/2	CCC (48)
Aln-Cideb Metabolic Dysfunction-Associated Steatotic Liver Disease	Regeneron Pharmaceuticals	P1/2	CC (47)
oa-235i Metabolic Dysfunction-Associated Steatotic Liver Disease	Oasis Pharmaceuticals, LLC	P1	CC (47)
ly3849891 Metabolic Dysfunction-Associated Steatotic Liver Disease	Eli Lilly and Company	P1	CC (46)
Tcr .Alpha..Beta. (Receptor), Anti-(Human P53 (Protein)) (Synthetic Human Single-Chain Precursor) Fusion Protein With Interleukin 2 (Human) Metabolic Dysfunction-Associated Steatotic Liver Disease	Altimmune, Inc.	P1	CC (46)
gh509 Metabolic Dysfunction-Associated Steatotic Liver Disease	1Globe Biomedical Co., Ltd.	P1/2	CC (45)
Akkermansia Muciniphila Metabolic Dysfunction-Associated Steatotic Liver Disease	Leeuwenhoek Laboratories Co. Ltd.	P1	CC (43)
b1344 Metabolic Dysfunction-Associated Steatotic Liver Disease	Tasly Biopharmaceuticals Co., Ltd.	P1	CC (43)
Bicalutamide Metabolic Dysfunction-Associated Steatotic Liver Disease	University of California, San Francisco	P1	CC (43)
Bmn 255 Metabolic Dysfunction-Associated Steatotic Liver Disease	BioMarin Pharmaceutical	P1	CC (43)
Gip Metabolic Dysfunction-Associated Steatotic Liver Disease	Dr Adnan Agha	P1/2	CC (43)
Miricorilant Metabolic Dysfunction-Associated Steatotic Liver Disease	Corcept Therapeutics	P1	CC (43)
qx1206 Metabolic Dysfunction-Associated Steatotic Liver Disease	1Globe Health Institute	P1	CC (43)
[6,6-2H2] D-glucose Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1	CC (42)
azd7503 Metabolic Dysfunction-Associated Steatotic Liver Disease	AstraZeneca	P1	CC (42)
bi 3006337 Metabolic Dysfunction-Associated Steatotic Liver Disease	Boehringer Ingelheim	P1	CC (42)
Deuterated Water Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1	CC (42)
Eudemine Injection Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1	CC (42)
Glucose, Anhydrous Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1	CC (42)
Insulin Human Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1	CC (42)
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R,R))- Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1	CC (42)
nnc0194-0499 Metabolic Dysfunction-Associated Steatotic Liver Disease	Novo Nordisk A/S	P1	CC (42)
Acetic Acid, Sodium Salt (1:1) Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1	C (39)
Alpelisib Metabolic Dysfunction-Associated Steatotic Liver Disease	Columbia University	P1	C (39)
bar502 Metabolic Dysfunction-Associated Steatotic Liver Disease	BAR Pharmaceuticals s.r.l.	P1	C (39)

Showing 51 to 100 of 131 assets

PreviousPage 2 of 3Next